https://www.selleckchem.com/pr....oducts/amredobresib.
Elderly patients with COVID-19 disease are at increased risk for adverse outcomes. Current data regarding disease characteristics and outcomes in this population are limited. To delineate the adverse factors associated with outcomes of COVID-19 patients ≥75 years of age. Retrospective cohort study. Patients were classified into mild/moderate, severe/very severe and critical disease (intubated) based on oxygen requirements. The primary outcome was in-hospital mortality. A total of 355 patients aged ≥75 years hospitalized with COVID-
Мне нравится
Комментарий
Перепост
